SCHEMBL14849755

SCHEMBL14849755

CC1(C)c2ccccc2-c2cc3c4cc5c(cc4n(-c4ccc(-c6ccc(-n7c8cc9c(cc8c8cc%10c(cc87)C(C)(C)c7ccccc7-%10)-c7ccccc7C9(C)C)cc6)cc4)c3cc21)C(C)(C)c1ccccc1-5

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PGR P06401 8/20 0.35
▸ PDK2 Q15119 5/20 0.31
▸ MLNR O43193 1/20 0.31
▸ NR1I2 O75469 1/20 0.31
▸ CHRM2 P08172 1/20 0.31
▸ ADRB1 P08588 1/20 0.31
▸ HTR1A P08908 1/20 0.31
▸ ADRA2A P08913 1/20 0.31
▸ CHRM1 P11229 1/20 0.31
▸ DRD2 P14416 1/20 0.31
▸ ADRA2B P18089 1/20 0.31
▸ ADRA2C P18825 1/20 0.31
▸ CHRM3 P20309 1/20 0.31
▸ DRD1 P21728 1/20 0.31
▸ SLC6A2 P23975 1/20 0.31
▸ HTR2A P28223 1/20 0.31
▸ HTR2C P28335 1/20 0.31
▸ SLC6A4 P31645 1/20 0.31
▸ ADRA1A P35348 1/20 0.31
▸ HRH1 P35367 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14849701 0.97 PGR (0.35) PGRPDK2HDAC4KDM4EATM
SCHEMBL14849835 0.96 PDK2 (0.37) PGRPDK2
SCHEMBL14849829 0.95 PGR (0.37) PGRPDK2MLNRNR1I2CHRM2
SCHEMBL783257 0.95 KDM4E (0.40) PGRHDAC4KDM4EATML3MBTL1
SCHEMBL14849824 0.95 PGR (0.34) PGRPDK2HDAC4KDM4EATM
SCHEMBL14849709 0.95 KDM4E (0.40) PGRHDAC4KDM4EATML3MBTL1
SCHEMBL14822535 0.95 KDM4E (0.40) PGRHDAC4KDM4EATML3MBTL1
SCHEMBL14852904 0.95 PGR (0.43) PGRPDK2KDM4E
SCHEMBL782525 0.92 L3MBTL1 (0.41) PGRPDK2HDAC4KDM4EATM
SCHEMBL14960765 0.92 PDK2 (0.35) PGRPDK2HDAC4KDM4EATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9309197-B2 Heterocyclic compound, organic light-emitting diode comprising the heterocyclic compound, and flat panel display device comprising the organic light-emitting diode SAMSUNG DISPLAY CO., LTD. (KR) 2016-04-12 — — US disclosed
US-9309197-B2 Heterocyclic compound, organic light-emitting diode comprising the heterocyclic compound, and flat panel display device comprising the organic light-emitting diode SAMSUNG DISPLAY CO., LTD. (KR) 2016-04-12 — — US disclosed
EP-2581365-A1 Heterocyclic compound, organic light-emitting diode comprising the heterocyclic compound, and flat panel display device comprising the organic light-emitting diode Samsung Display Co., Ltd. (KR) 2013-04-17 — — EP disclosed
US-20130087768-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE COMPRISING THE HETEROCYCLIC COMPOUND, AND FLAT PANEL DISPLAY DEVICE COMPRISING THE ORGANIC LIGHT-EMITTING DIODE SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2013-04-11 — — US disclosed
US-20130087768-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE COMPRISING THE HETEROCYCLIC COMPOUND, AND FLAT PANEL DISPLAY DEVICE COMPRISING THE ORGANIC LIGHT-EMITTING DIODE SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2013-04-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130087768-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE COMPRISING THE HETEROCYCLIC COMPOUND, AND FLAT PANEL DISPLAY DEVICE COMPRISING THE ORGANIC LIGHT-EMITTING DIODE DRD1, DRD2, DRD3 PGR 287/4885PDK2 1094/4885MLNR 2657/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback